Close Menu

NEW YORK (GenomeWeb) – The University of Liverpool said on Wednesday that it has been awarded about £20.5 million ($33.5 million) to build an incubator space for small and medium-sized businesses operating in the personalized medicine arena.

The Liverpool Bio Innovation Hub will encompass more than 6,000 square meters and will include laboratory and office space, allowing commercial access to biobank technologies and genomic, proteomic, and metabolomic equipment.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Hastings Center's Erik Parens argues in a Scientific American opinion piece that the current pandemic underscores the need to reconsider the hope placed in genomic medicine. 

The Los Angeles Times writes that Operation Warp Speed has an ambitious timeline for developing a COVID-19 vaccine.

The Sydney Morning Herald reports that Australia is launching its trial of preconception carrier testing Tuesday.

In PNAS this week: autosomal genes commonly affected by loss-of-function variants, variants implicated in testis development disorders, and more.

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.